Latest news with #RM2.28
The Sun
25-06-2025
- The Sun
Perlis Customs thwarts attempt to smuggle contraband worth over RM2 mln
PADANG BESAR: The Perlis Customs Department (JKDM) thwarted an attempt to smuggle various goods, including cannabis, ketum leaves, 'cloned' vehicles and cigarettes, with a total seizure value of RM2.45 million in several separate operations conducted between May and June Its director, Ismail Hashim said the biggest seizure involved cannabis flowers, which are more expensive than compressed slabs of leaves, weighing 22.855 kilogrammes (kg) and worth RM2.28 million, near the Malaysia-Thailand border gate at Jalan Sadao here on June 19. 'Our team came across a Proton Saga BLM (base line model) vehicle parked without a driver near the Malaysia-Thailand border gate and an inspection found 40 airtight transparent plastic packages of cannabis flowers in the back passenger area. 'The syndicate's modus operandi is to leave the vehicle unmanned in Malaysian territory after crossing the border before an accomplice picks up the car. This amount of cannabis can be used by 114,000 addicts in Peninsular Malaysia,' he said at a press conference here today. Meanwhile, Ismail said three more seizures were made involving 1,975 kg of ketum leaves, worth RM108,625, from inspections in the bush area near the Malaysia-Thailand border security checkpoint here between May 30 and 31. He said in another two cases on May 30, his raiding party found two vehicles abandoned in the bush, a Mitsubishi Pajero carrying 647 kg of ketum leaves, worth RM35,585, and an Isuzu Dmax carrying 1,036 kg of ketum leaves (RM56,980) while the seizure on May 31 involved 292 kg of ketum leaves (RM16,060). In addition, Ismail said two cloned vehicles were also seized, These involved a Volvo XC60 worth RM40,000 (with RM55,000 tax payable) on June 14 in Kuala Ketil, Kedah and a Honda Jazz worth RM15,000 (RM20,625 tax payable) seized on June 19 in Beseri near here. 'Inspections found that both vehicles used fake registration numbers and were prohibited goods imported without a valid permit,' he said, adding that his party also seized 3,040 contraband cigarettes worth RM936.40 (RM2,100.04 tax payable) at Felda Rimba Emas near here on June 19. He also said that all the cases were being investigated under the Dangerous Drugs Act 1952, the Poisons Act 1952 and the Customs Act 1967, and added that his party would continue to intensify operations to combat smuggling of contraband into the state.
Barnama
25-06-2025
- Barnama
Perlis Customs Thwarts Attempt To Smuggle Contraband Worth Over RM2 Mln
PADANG BESAR, June 25 (Bernama) -- The Perlis Customs Department (JKDM) thwarted an attempt to smuggle various goods, including cannabis, ketum leaves, "cloned" vehicles and cigarettes, with a total seizure value of RM2.45 million in several separate operations conducted between May and June. Its director, Ismail Hashim said the biggest seizure involved cannabis flowers, which are more expensive than compressed slabs of leaves, weighing 22.855 kilogrammes (kg) and worth RM2.28 million, near the Malaysia-Thailand border gate at Jalan Sadao here on June 19. 'Our team came across a Proton Saga BLM (base line model) vehicle parked without a driver near the Malaysia-Thailand border gate and an inspection found 40 airtight transparent plastic packages of cannabis flowers in the back passenger area. 'The syndicate's modus operandi is to leave the vehicle unmanned in Malaysian territory after crossing the border before an accomplice picks up the car. This amount of cannabis can be used by 114,000 addicts in Peninsular Malaysia,' he said at a press conference here today. Meanwhile, Ismail said three more seizures were made involving 1,975 kg of ketum leaves, worth RM108,625, from inspections in the bush area near the Malaysia-Thailand border security checkpoint here between May 30 and 31. He said in another two cases on May 30, his raiding party found two vehicles abandoned in the bush, a Mitsubishi Pajero carrying 647 kg of ketum leaves, worth RM35,585, and an Isuzu Dmax carrying 1,036 kg of ketum leaves (RM56,980) while the seizure on May 31 involved 292 kg of ketum leaves (RM16,060). In addition, Ismail said two cloned vehicles were also seized. These involved a Volvo XC60 worth RM40,000 (with RM55,000 tax payable) on June 14 in Kuala Ketil, Kedah and a Honda Jazz worth RM15,000 (RM20,625 tax payable) seized on June 19 in Beseri near here. 'Inspections found that both vehicles used fake registration numbers and were prohibited goods imported without a valid permit,' he said, adding that his party also seized 3,040 contraband cigarettes worth RM936.40 (RM2,100.04 tax payable) at Felda Rimba Emas near here on June 19. He also said that all the cases were being investigated under the Dangerous Drugs Act 1952, the Poisons Act 1952 and the Customs Act 1967, and added that his party would continue to intensify operations to combat smuggling of contraband into the state.
Yahoo
28-05-2025
- Business
- Yahoo
Estimating The Intrinsic Value Of Apex Healthcare Berhad (KLSE:AHEALTH)
The projected fair value for Apex Healthcare Berhad is RM2.28 based on 2 Stage Free Cash Flow to Equity Current share price of RM2.12 suggests Apex Healthcare Berhad is potentially trading close to its fair value Our fair value estimate is 7.5% lower than Apex Healthcare Berhad's analyst price target of RM2.47 Does the May share price for Apex Healthcare Berhad (KLSE:AHEALTH) reflect what it's really worth? Today, we will estimate the stock's intrinsic value by taking the expected future cash flows and discounting them to today's value. One way to achieve this is by employing the Discounted Cash Flow (DCF) model. Believe it or not, it's not too difficult to follow, as you'll see from our example! Remember though, that there are many ways to estimate a company's value, and a DCF is just one method. If you still have some burning questions about this type of valuation, take a look at the Simply Wall St analysis model. We've found 21 US stocks that are forecast to pay a dividend yield of over 6% next year. See the full list for free. We are going to use a two-stage DCF model, which, as the name states, takes into account two stages of growth. The first stage is generally a higher growth period which levels off heading towards the terminal value, captured in the second 'steady growth' period. To start off with, we need to estimate the next ten years of cash flows. Seeing as no analyst estimates of free cash flow are available to us, we have extrapolate the previous free cash flow (FCF) from the company's last reported value. We assume companies with shrinking free cash flow will slow their rate of shrinkage, and that companies with growing free cash flow will see their growth rate slow, over this period. We do this to reflect that growth tends to slow more in the early years than it does in later years. Generally we assume that a dollar today is more valuable than a dollar in the future, and so the sum of these future cash flows is then discounted to today's value: 2025 2026 2027 2028 2029 2030 2031 2032 2033 2034 Levered FCF (MYR, Millions) RM66.1m RM72.6m RM78.4m RM83.6m RM88.5m RM93.0m RM97.4m RM101.6m RM105.8m RM110.1m Growth Rate Estimate Source Est @ 12.54% Est @ 9.87% Est @ 8.00% Est @ 6.69% Est @ 5.78% Est @ 5.14% Est @ 4.69% Est @ 4.37% Est @ 4.15% Est @ 4.00% Present Value (MYR, Millions) Discounted @ 8.4% RM60.9 RM61.8 RM61.6 RM60.6 RM59.1 RM57.4 RM55.4 RM53.4 RM51.3 RM49.2 ("Est" = FCF growth rate estimated by Simply Wall St)Present Value of 10-year Cash Flow (PVCF) = RM571m We now need to calculate the Terminal Value, which accounts for all the future cash flows after this ten year period. For a number of reasons a very conservative growth rate is used that cannot exceed that of a country's GDP growth. In this case we have used the 5-year average of the 10-year government bond yield (3.6%) to estimate future growth. In the same way as with the 10-year 'growth' period, we discount future cash flows to today's value, using a cost of equity of 8.4%. Terminal Value (TV)= FCF2034 × (1 + g) ÷ (r – g) = RM110m× (1 + 3.6%) ÷ (8.4%– 3.6%) = RM2.4b Present Value of Terminal Value (PVTV)= TV / (1 + r)10= RM2.4b÷ ( 1 + 8.4%)10= RM1.1b The total value is the sum of cash flows for the next ten years plus the discounted terminal value, which results in the Total Equity Value, which in this case is RM1.6b. To get the intrinsic value per share, we divide this by the total number of shares outstanding. Compared to the current share price of RM2.1, the company appears about fair value at a 7.2% discount to where the stock price trades currently. Valuations are imprecise instruments though, rather like a telescope - move a few degrees and end up in a different galaxy. Do keep this in mind. The calculation above is very dependent on two assumptions. The first is the discount rate and the other is the cash flows. If you don't agree with these result, have a go at the calculation yourself and play with the assumptions. The DCF also does not consider the possible cyclicality of an industry, or a company's future capital requirements, so it does not give a full picture of a company's potential performance. Given that we are looking at Apex Healthcare Berhad as potential shareholders, the cost of equity is used as the discount rate, rather than the cost of capital (or weighted average cost of capital, WACC) which accounts for debt. In this calculation we've used 8.4%, which is based on a levered beta of 0.800. Beta is a measure of a stock's volatility, compared to the market as a whole. We get our beta from the industry average beta of globally comparable companies, with an imposed limit between 0.8 and 2.0, which is a reasonable range for a stable business. Check out our latest analysis for Apex Healthcare Berhad Strength Debt is not viewed as a risk. Weakness Earnings declined over the past year. Dividend is low compared to the top 25% of dividend payers in the Pharmaceuticals market. Opportunity Annual earnings are forecast to grow faster than the Malaysian market. Current share price is below our estimate of fair value. Threat Dividends are not covered by cash flow. Annual revenue is forecast to grow slower than the Malaysian market. Although the valuation of a company is important, it shouldn't be the only metric you look at when researching a company. The DCF model is not a perfect stock valuation tool. Preferably you'd apply different cases and assumptions and see how they would impact the company's valuation. For example, changes in the company's cost of equity or the risk free rate can significantly impact the valuation. For Apex Healthcare Berhad, we've compiled three relevant elements you should assess: Risks: Consider for instance, the ever-present spectre of investment risk. We've identified 2 warning signs with Apex Healthcare Berhad , and understanding them should be part of your investment process. Future Earnings: How does AHEALTH's growth rate compare to its peers and the wider market? Dig deeper into the analyst consensus number for the upcoming years by interacting with our free analyst growth expectation chart. Other Solid Businesses: Low debt, high returns on equity and good past performance are fundamental to a strong business. Why not explore our interactive list of stocks with solid business fundamentals to see if there are other companies you may not have considered! PS. The Simply Wall St app conducts a discounted cash flow valuation for every stock on the KLSE every day. If you want to find the calculation for other stocks just search here. Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Free Malaysia Today
06-05-2025
- Business
- Free Malaysia Today
After 58 days, defence wraps up Najib's 1MDB case
Former prime minister Najib Razak is standing trial on 25 charges of abuse of power and money laundering over funds amounting to RM2.28 billion. PUTRAJAYA : Former prime minister Najib Razak's 1MDB defence in the High Court concluded today after 58 days of trial. Lawyer Shafee Abdullah told Justice Collin Lawrence Sequerah that the defence was wrapping up its case today, after calling its last witness, Tay Eue Kam. The hearing for the defence began on Dec 2 last year. A total of 26 witnesses were called, including former Goldman Sachs banker Roger Ng, former inspector-general of police Fuzi Harun and ex-1MDB chairman Lodin Wok Kamaruddin. Sequerah set Oct 21 to 31 to hear oral submissions from the defence and prosecution. 'The defence must file its written submissions by Sept 30 and the prosecution must file their replies by Oct 10,' he said. The prosecution's case had earlier taken up 235 days in the trial which began on Aug 28, 2019. Besides Shafee, Najib was also represented by lawyers Tania Scivetti and Wan Azwan Aiman Wan Fakhruddin. Deputy public prosecutors Kamal Baharin Omar, Ahmad Akram Gharib, Mustaffa P Kunyalam, T Deepa Nair and Nadia Izhar appeared for the prosecution. Najib is standing trial on 25 charges of abuse of power and money laundering over funds amounting to RM2.28 billion deposited into his AmBank accounts between February 2011 and December 2014.
Free Malaysia Today
05-05-2025
- Business
- Free Malaysia Today
Forensic examiner unable to verify Najib's signature on documents
Najib Razak is on trial for abuse of power and money laundering over funds amounting to RM2.28 billion deposited into his AmBank accounts between February 2011 and December 2014. (EPA Images) PUTRAJAYA : A forensic document examiner told the Najib Razak 1MDB trial today she could not determine the veracity of signatures on several company documents allegedly signed by the former prime minister. Tay Eue Kam said she only received photocopies of the documents, including the minutes of a meeting between 1MDB's board of advisers chairman (Najib) and then company CEO Shahrol Azral Ibrahim Halmi. She said that because the documents were only photocopies, she was unable to use a microscope or any other device to verify their authenticity. 'Several dissimilarities were identified. But, (to get) a definitive conclusion requires an examination of the original document,' she said. Asked by Najib's lawyer, Shafee Abdullah, whether the signatures could have been lifted from another document and pasted onto the documents she was analysing, Tay said she could not exclude the possibility. 'It was rather impossible to examine (whether the signatures were copied and pasted) with this quality (of photocopies),' she said. Najib is standing trial on 25 charges of abuse of power and money laundering over funds amounting to RM2.28 billion deposited into his AmBank accounts between February 2011 and December 2014. Earlier today, Shafee told the court the defence might call another witness from Bukit Aman before they close their case.
